Small Caps Small Caps

Astral Resources (ASX: AAR) managing director Marc Ducler joins Small Caps to discuss the positive results obtained into a study into the potential development of the 100%-owned Mandilla gold project in Western Australia.

One of the largest undeveloped free-milling open pit gold development projects in the rich Kalgoorlie region, Mandilla is forecast to produce around 100,000 ounces per annum at an average feed grade of 1.30 grams per tonnes gold over an initial 7.4-year period.

The Astral board is now assessing a move to the pre-feasibility phase for the project after the scoping study results highlighted commercial viability of a stand-alone gold mining operation.

Key financial outcomes from the scoping study include free cash flow of $740 million and a net present value (8%) of $442 million.

Astral believes there is significant growth opportunities at Mandilla and continues to advance exploration and resource definition efforts as well as at the company’s nearby Feysville gold project.

Article:https://smallcaps.com.au/astral-resources-releases-positive-scoping-study-mandilla-gold-project/

For more information on Astral Resources:https://smallcaps.com.au/stocks/asx-aar/
See omnystudio.com/listener for privacy information.

92 Energy (ASX: 92E) chief executive officer Siobhan Lancaster joins Small Caps to discuss the company’s timely discovery of a potential new zone of mineralisation at its Gemini uranium find in Canada’s world-class Athabasca Basin.

The new parallel structure was identified in a recent follow-up campaign to the September 2021 Gemini uranium discovery.

The hole returned uranium mineralisation and key uranium pathfinders with intense alteration, making it ripe for follow-up drilling and assay results to further confirm the potential of the new find are expected imminently.

92 Energy’s uranium exploration is targeting high-grade unconformity-associated uranium in the Athabasca Basin, home of the richest uranium fields in the world.

The uncovering of the new structure has highlighted the potential for 92 Energy to encounter other new zones along the Gemini trend, which remains largely untested.

To date there has been very limited drilling at the newly discovered parallel structure, with around 600m of virtually untested strike length available to be tested in the future.

Uranium prices have been particularly strong recently, surging to US$69 per pound.

Article:https://smallcaps.com.au/92-energy-hits-potential-new-uranium-zone-gemini/

For more information on 92 Energy:https://smallcaps.com.au/stocks/asx-92e/
See omnystudio.com/listener for privacy information.

PharmAust (ASX: PAA) chief executive officer Michael Thurn joins Small Caps to discuss his appointment to the company and recent trial developments.

The company recently released interim analysis of data from a Phase 1 clinical trial of its lead drug candidate monepantel (MPL) to treat motor neurone disease/amyotrophic lateral sclerosis (MND/ALS).

Results from an interim analysis of the trial indicated that neurofilament light chain (Nfl) protein concentrations in the plasma of participants in its Phase 1 clinical trial do not increase following MPL treatment – a positive sign.

PharmAust hopes that MPL could eventually receive orphan drug designation by the Therapeutics Goods Administration (TGA) and US Food and Drug Administration (FDA) for motor neurone disease, which affects over 350,000 people globally and kills more than 100,000 people yearly.

Article:https://smallcaps.com.au/pharmaust-names-highly-experienced-biotech-specialist-chief-executive-officer/https://smallcaps.com.au/pharmaust-interim-phase-1-data-mpl-inhibit-motor-neurone-disease/

For more information on PharmAust:https://smallcaps.com.au/stocks/asx-paa/ 
See omnystudio.com/listener for privacy information.

Piedmont Lithium (NASDAQ: PLL) president and chief executive officer Keith Phillips joins Small Caps to discuss the latest progress made at the company’s North American Lithium (NAL) operation in Canada.

Articles: https://smallcaps.com.au/ghana-sovereign-wealth-fund-backs-atlantic-lithium-piedmont-mine/https://smallcaps.com.au/maiden-cash-flow-sayona-piedmont-canada-lithium-alliance/https://smallcaps.com.au/piedmont-lithium-banks-pre-payment-inaugural-sale-nal-concentrate/

For more information on Piedmont Lithium:https://smallcaps.com.au/stocks/asx-pll/
See omnystudio.com/listener for privacy information.

Elevate Uranium (ASX: EL8) managing director and chief executive officer Murray Hill joins Small Caps to discuss the expansion of the company’s drilling campaign at the Koppies uranium project in Namibia.

The company recently added an additional rig to its Koppies program, with a three rig, reverse circulation program targeting the finalisation of an interim resource for Koppies 3 during October 2023.

This will be followed by further drilling to test areas located outside of the interim resource zone, with results aimed at expanding the current JORC resource of 20.3 million pounds of uranium identified at Koppies 1 and 2.

The company is also preparing to follow up previous exploration success at Capri where Elevate has already identified multiple additional exploration targets.

The company is working to obtain new land access agreements prior to bringing a rig in for the exploration campaign.

Article:https://smallcaps.com.au/elevate-uranium-increases-drilling-operation-koppies-project-namibia/

For more information on Elevate Uranium:https://smallcaps.com.au/stocks/asx-el8/
See omnystudio.com/listener for privacy information.

James Bay Minerals (ASX: JBY) executive director Andrew Dornan joins Small Caps to discuss the company’s highly anticipated listing on the ASX today.

Named after the “red hot” James Bay lithium province in Quebec, the company made its ASX appearance after successfully completing a highly sort after $6 million initial public offer.

Backed by its vastly experienced board and management, James Bay Minerals already holds one of the largest lithium exploration tenures in the area with around 224 square kilometres of prospective ground on its books.

The company currently holds 104 claims in James Bay and has entered into three binding agreements under which will provide it with an opportunity to acquire a 100% interest in a further 333 claims.

With a significant portfolio of ready to test exploration assets and cash in hand, James Bay Minerals is ready to hit the ground running to further evaluate a number of prospective targets

Articles:https://smallcaps.com.au/james-bay-minerals-set-to-list-big-lithium-reputation/ https://smallcaps.com.au/james-bay-minerals-world-class-lithium-team-asx-listing/

For more information on James Bay Minerals:https://smallcaps.com.au/stocks/asx-jby/
See omnystudio.com/listener for privacy information.